Seres Therapeutics (Germany) Price on September 30, 2024

1S9 Stock  EUR 0.84  0.01  1.20%   
If you're considering investing in Seres Stock, it is important to understand the factors that can impact its price. As of today, the current price of Seres Therapeutics stands at 0.84, as last reported on the 13th of December 2024, with the highest price reaching 0.84 and the lowest price hitting 0.84 during the day. Seres Therapeutics appears to be out of control, given 3 months investment horizon. Seres Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0257, which indicates the firm had a 0.0257% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Seres Therapeutics, which you can use to evaluate the volatility of the company. Please review Seres Therapeutics' Semi Deviation of 6.35, coefficient of variation of 8477.98, and Risk Adjusted Performance of 0.0177 to confirm if our risk estimates are consistent with your expectations.
  
Seres Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0257

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns1S9
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.94
  actual daily
70
70% of assets are less volatile

Expected Return

 0.2
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.03
  actual daily
2
98% of assets perform better
Based on monthly moving average Seres Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Seres Therapeutics by adding it to a well-diversified portfolio.

Seres Therapeutics Valuation on September 30, 2024

It is possible to determine the worth of Seres Therapeutics on a given historical date. On September 30, 2024 Seres was worth 0.85 at the beginning of the trading date compared to the closed value of 0.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Seres Therapeutics stock. Still, in general, we apply an absolute valuation method to find Seres Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Seres Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Seres Therapeutics' related companies.
 Open High Low Close Volume
  0.78    0.78    0.74    0.74    800.00  
09/30/2024
  0.85    0.90    0.85    0.90    300.00  
  0.83    0.83    0.76    0.76    500.00  
Backtest Seres Therapeutics  |  Seres Therapeutics History  |  Seres Therapeutics Valuation   PreviousNext  
Open Value
0.85
0.9
Closing Value
24.68
Upside

Seres Therapeutics Trading Date Momentum on September 30, 2024

On October 01 2024 Seres Therapeutics was traded for  0.76  at the closing time. The highest daily price throughout the period was 0.83  and the lowest price was  0.76 . The daily volume was 500. The net trading volume on 10/01/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 15.56% . The trading price change to current closing price is 25.56% .

Seres Therapeutics Fundamentals Correlations and Trends

By evaluating Seres Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Seres Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Seres financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Seres Therapeutics Stock history

Seres Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Seres is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Seres Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Seres Therapeutics stock prices may prove useful in developing a viable investing in Seres Therapeutics
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. SERES THERAPEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 155 people.

Seres Therapeutics Stock Technical Analysis

Seres Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Seres Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Seres Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Seres Therapeutics Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Seres Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Seres Therapeutics December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Seres Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Seres Therapeutics shares will generate the highest return on investment. By undertsting and applying Seres Therapeutics stock market strength indicators, traders can identify Seres Therapeutics entry and exit signals to maximize returns

Seres Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Seres Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Seres Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Seres to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Seres Stock analysis

When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities